Early and Late Results of Valvular Surgery for Carcinoid Heart Disease
Javier G. Castillo, Farzan Filsoufi, Parwis B. Rahmanian, Anelechi Anyanwu, Jerome S. Zacks, Richard R.P. Warner, and David H. Adams
J. Am. Coll. Cardiol. 2008;51;1507-1509
Early Bioprosthetic Valve Deterioration After Carcinoid Plaque Deposition
Castillo JG, Filsoufi F, Rahmanian PB, Zacks JS, Warner RP, Adams, DH
Ann Thorac Surg 2009;87:321
Michael Shafir MD, Richard RP Warner MD, Sheilah Gonsalves MD, Jerome S Zacks MD, Lynn Ratner MD, Michelle Kim MD
Recognizing Carcinoid Heart Disease and Timing of Cardiac and Abdominal Procedures
Presented as a Poster at the March 2011 ENETS (European Neuroendocrine Tumor Society) International Conference
Jerome S Zacks MD, Michael Shafir MD, Javier Castillo MD,
Ms. Jacqueline Choi, Richard R P Warner MD
Mount Sinai School of Medicine, New York, New York
Ultrasonography of Splenic Infarct
Hsu-Chong Yeh MD, Jerome S Zacks MD and Roy Jurado MD.
The Mount Sinai Journal of Medicine, NY, Vol 48, No. 5, September-October 1981
Percutaneous closure of a patent foramen ovale in left-sided carcinoid heart disease
Chaudhari, P. R., Abergel, J., Warner, R. R., Zacks, J., Love, B. A., Halperin, J. L., Adler, E.
Nat Clin Pract Cardiovasc Med. 2007 Aug;4(8):455-9.
An Analysis of Global Research Trends in Cardiology over the Last Two Decades
Rohit Kapoor, Soumya Sachdeva, Jerome Zacks MD FACC FCCP
Journal of Clinical and Diagnostic Research. 2015 Jan, Vol-9(1): OC06-OC09
Early Recurrence of Carcinoid Valvulopathy after Valve Replacement
Zacks JS, Canovas E, Lavine R, Warner RRP
Abstract (poster) presented at the 2014 ENETS meetings
Early Recurrence of Carcinoid Valvulopathy after Valve Replacement
Zacks JS, Castillo J, Warner RRP, Canovas E, Lavine R, Adams, D
Abstract (poster) presented at the 2014 NANETS meetings
Telotristat Etiprate Appears to Halt Carcinoid Heart Disease
Zacks JS, Lavine R, Ratner L, Warner RP
Abstract (poster) presented at the March 2016 ENETS (European Neuroendocrine Tumor Society) in Barcelona. It is the first evidence released in the world showing that there is a drug which can halt the progression (or prevent) Carcinoid Heart Disease.
